Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jose C. Armario"'
Autor:
Jose J. Pereyra-Rodriguez, Esther S. Baldrich, Ricardo Ruiz-Villaverde, Eulalia B. Torres, Pablo de la C. Dobao, Ignasi F. Nart, Ángeles F. Menéndez, Ana Martin-Santiago, Javier M. Miquel, Juan F. Silvestre, Jose C. Armario-Hita
Publikováno v:
Acta Dermato-Venereologica, Vol 103 (2023)
Despite emerging evidence and advances in the management of atopic dermatitis there a lack of consensus regarding the diagnostic criteria, therapeutic approach, method to assess severity, and patient follow-up for this condition. An expert consensus
Externí odkaz:
https://doaj.org/article/8ef9b7ee37d64e0889d15db19bc93c2c
Autor:
Antonio J. Diaz, Miguel A. Rosety, Jose C. Armario, Manuel J. Bandez, Natalia Garcia-Gomez, Eduardo Sanchez-Sanchez, Jara Diaz, Cristina Castejon-Riber, Marco Bernardi, Manuel Rosety-Rodriguez M, Francisco J. Ordonez, Ignacio Rosety
Publikováno v:
Nutrients, Vol 15, Iss 21, p 4563 (2023)
Fatigue and musculoskeletal pain are also frequent in patients with psoriasis (PsO) without arthritis (PsA). The current study aimed to assess the impact of an intervention program based on aerobic training to reduce fatigue and musculoskeletal pain
Externí odkaz:
https://doaj.org/article/0dfef4b30c4f4d2aa5fc508fd95b265c
Autor:
Fiorella Vasquez Chinchay, Manuel Galán-Gutiérrez, Jose C. Armario-Hita, Amalia Pérez-Gil, Ricardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire
Publikováno v:
F1000Research, Vol 11 (2022)
Background: Psoriasis is a chronic inflammatory disease which can impact quality of life. In the past decade multiple biologic treatments have been released with encouraging results. Guselkumab is a monoclonal antibody targeting IL-23p19. Multiple ra
Externí odkaz:
https://doaj.org/article/407b086b973448d79f9c3720c708bd7d
Autor:
Ricardo Ruiz-Villaverde, Fiorella Vasquez-Chinchay, Lourdes Rodriguez-Fernandez-Freire, Jose C. Armario-Hita, Amalia Pérez-Gil, Manuel Galán-Gutiérrez
Publikováno v:
Life, Vol 12, Iss 9, p 1412 (2022)
A fast skin clearance is the main goal to achieve in psoriasis treatment. Patients that present a fast and exceptional improvement with treatment are called super-responders (SR). There is no consensus on the definition of SR with respect to psoriasi
Externí odkaz:
https://doaj.org/article/168265c2256b44b0aeaabfef636ce2a0
Autor:
Ricardo Ruiz‐Villaverde, Fiorella Vasquez Chinchay, Lourdes Rodriguez‐Fernandez‐Freire, Jose C. Armario‐Hita, Amalia Pérez‐Gil, Manuel Galán‐Gutiérrez
Publikováno v:
Dermatologic Therapy. 35
Psoriasis (PSO) is an inflammatory disease that emerges as a dysregulation of the interleukin 23 (IL23)/Th17 axis. There are many biologic alternatives to treat PSO that are administered monthly, every 2 months and every 3 months. Guselkumab (GUS) is
Autor:
Juan Francisco Silvestre, M. J. Tribó, José C. Armario‐Hita, Miguel Ángel Calleja‐Hernández, Francisco Javier Ortiz‐Frutos, José Luis Poveda, John Shepherd, Esther Serra‐Baldrich
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 1, Pp 191-200 (2024)
Abstract Background Prurigo nodularis (PN) is a chronic, debilitating dermatologic disease characterised by the presence of highly pruritic nodular lesions. PN highly impacts on patients' quality of life as there are no specific treatments available
Externí odkaz:
https://doaj.org/article/7949258262c44333a3d6334d2712caa2
Autor:
Ricardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire, Jose C. Armario-Hita, Amalia Pérez-Gil, Fiorella Vasquez Chinchay, Manuel Galán-Gutiérrez
Publikováno v:
F1000Research. 11:1178
Background: Psoriasis is a chronic inflammatory disease which can impact quality of life. In the past decade multiple biologic treatments have been released with encouraging results. Guselkumab is a monoclonal antibody targeting IL-23p19. Multiple ra
Autor:
L. Rodriguez-Fernandez-Freire, Ricardo Ruiz-Villaverde, Jose C. Armario-Hita, Fiorella Vasquez, Amalia Perez-Gil, Leandro Martinez-Pilar, Manuel Galan-Gutierrez
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB164
Autor:
Jose C Armario-Hita, Manuel Rosety-Rodriguez, Francisco Brenes-Martín, Ignacio Rosety, María Teresa Pery, Miguel Angel Rosety, Francisco Javier Ordonez
Publikováno v:
Medicine & Science in Sports & Exercise. 48:264